Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
63,366,577
-
Shares change
-
+8,063,894
-
Total reported value, excl. options
-
$1,801,775,442
-
Value change
-
+$234,357,441
-
Put/Call ratio
-
10%
-
Number of buys
-
78
-
Number of sells
-
-58
-
Price
-
$28.53
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q3 2022
171 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share as of Q3 2022.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,366,577 shares
of 75,607,738 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include FMR LLC (9,360,160 shares), ORBIMED ADVISORS LLC (5,525,926 shares), Bain Capital Life Sciences Investors, LLC (4,831,307 shares), PERCEPTIVE ADVISORS LLC (3,470,563 shares), EcoR1 Capital, LLC (3,460,208 shares), BOXER CAPITAL, LLC (3,421,541 shares), STATE STREET CORP (3,324,062 shares), VANGUARD GROUP INC (3,196,045 shares), BlackRock Inc. (2,821,344 shares), and ArrowMark Colorado Holdings LLC (2,550,779 shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.